Key result
Elevated Atherogenic Index of Plasma linked to ~127% higher risk of incident cardiometabolic multimorbidity.
Why the study?
Does elevated Atherogenic Index of Plasma increase the risk of incident cardiometabolic multimorbidity in middle-aged and elderly Chinese adults?
Cohort (n=5,401)
Does elevated Atherogenic Index of Plasma increase the risk of incident cardiometabolic multimorbidity in middle-aged and elderly Chinese adults?
Hazard Ratio: 2.27 (95% CI 1.21–4.26)
Long-term elevation and persistently high trajectories of the Atherogenic Index of Plasma are independent risk factors for cardiometabolic multimorbidity in middle-aged and elderly adults.
The association between long-term dynamic changes in the Atherogenic Index of Plasma (AIP) and the risk of cardiometabolic multimorbidity (CMM) has not been fully elucidated. This study was designed to investigate this association in a middle-aged and elderly Chinese population. Based on the China Health and Retirement Longitudinal Study (CHARLS), we included 5,401 participants without CMM at baseline (2015). Cumulative AIP (cumAIP) was calculated based on data from 2011 to 2015. Group-based trajectory modeling (GBTM) was used to identify distinct AIP change patterns over the follow-up period. Multivariable Cox proportional hazards models were used to assess the associations between cumAIP, AIP trajectories, and incident CMM. During follow-up, compared to the lowest quartile of cumAIP (Q1), participants in the highest quartile (Q4) had a significantly increased risk of CMM (adjusted HR: 2.27, 95% CI: 1.21–4.26). Similarly, compared to the persistently low AIP trajectory group, those with persistently moderate-level (HR = 1.76, 95% CI: 1.38–2.26) and high-level (HR = 1.84, 95% CI: 1.42–2.37) trajectories faced elevated risks. The risk was most pronounced for the triple CMM combination (diabetes, heart disease, and stroke). A nonlinear dose-response relationship was observed between cumAIP and CMM risk. Subgroup and sensitivity analyses confirmed the robustness of these findings. This longitudinal study demonstrates, for the first time, that long-term elevation in AIP and persistently high AIP trajectories are independent risk factors for CMM in Chinese middle-aged and elderly adults. Monitoring the dynamic changes of AIP is crucial for the early identification of high-risk individuals to guide targeted interventions.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) conducted a cohort in Cardiometabolic multimorbidity (CMM) (n=5,401). Highest quartile of cumulative Atherogenic Index of Plasma (cumAIP Q4) vs. Lowest quartile of cumulative Atherogenic Index of Plasma (cumAIP Q1) was evaluated on Incident cardiometabolic multimorbidity (CMM) (HR 2.27, 95% CI 1.21-4.26). Long-term elevation in the Atherogenic Index of Plasma (highest vs lowest quartile) was associated with a significantly increased risk of incident cardiometabolic multimorbidity (HR 2.27; 95% CI 1.21-4.26).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: